In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.
In spring 2021, ACCC and Harborside hosted a Virtual Summit to Define on the Role Oncology Advanced Practitioners in Equitable Cancer Care Delivery. Each summit session focused one specific domain of care delivery—Care Coordination and Communication; Clinical Trials; and Acknowledging and Mitigating Implicit Bias.
“I think it’s critically important for clinicians to really be aware of the concept of implicit bias as we’re assessing patients for trials.”
Colleen Lewis, MSN, ANP-BC, AOCNP
Director of Clinical Operations, Phase I Program; Interim Director, Infusion Center Clifton
The Winship Cancer Institute of Emory University,
Atlanta, GA
This mini-podcast—and two upcoming shows—will share key themes from the Summit. Look for more findings coming soon to the ACCC website.
Thank you to Pfizer Oncology for their collaboration and support in hosting the ACCC-Harborside Virtual Summit.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 30, 2026
June 30, 2026
